title: Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults.
abstract: Serum amyloid A (SAA) is, like C-reactive protein (CRP), an acute phase protein and can be used as a diagnostic, prognostic or therapy follow-up marker for many diseases. Increases in serum levels of SAA are triggered by physical insults to the host, including infection, trauma, inflammatory reactions and cancer. The order of magnitude of increase in SAA levels varies considerably, from a 10- to 100- fold during limited inflammatory events to a 1000-fold increase during severe bacterial infections and acute exacerbations of chronic inflammatory diseases. This broad response range is reflected by SAA gene duplications resulting in a cluster encoding several SAA variants and by multiple biological functions of SAA. SAA variants are single-domain proteins with simple structures and few post-translational modifications. SAA1 and SAA2 are inducible by inflammatory cytokines, whereas SAA4 is constitutively produced. We review here the regulated expression of SAA in normal and transformed cells and compare its serum levels in various disease states. At low concentrations (10-100 ng/ml), early in an inflammatory response, SAA induces chemokines or matrix degrading enzymes via Toll-like receptors and functions as an activator and chemoattractant through a G protein-coupled receptor. When an infectious or inflammatory stimulus persists, the liver continues to produce more SAA (≥ 1000 ng/ml) to become an antimicrobial agent by functioning as a direct opsonin of bacteria or by interference with virus infection of host cells. Thus, SAA regulates innate and adaptive immunity and this information may help to design better drugs to treat specific diseases.
authors.forename: Mieke
authors.initials: M
authors.lastname: De Buck
authors.forename: Mieke
authors.initials: M
authors.lastname: Gouwy
authors.forename: Ji Ming
authors.initials: JM
authors.lastname: Wang
authors.forename: Jacques
authors.initials: J
authors.lastname: Van Snick
authors.forename: Ghislain
authors.initials: G
authors.lastname: Opdenakker
authors.forename: Sofie
authors.initials: S
authors.lastname: Struyf
authors.affiliation: University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Molecular Immunology, Minderbroedersstraat 10, 3000 Leuven, Belgium. jo.vandamme@kuleuven.be.
authors.forename: Jo
authors.initials: J
authors.lastname: Van Damme
mesh_terms: D056914:Genomic Structural Variation / Q000235:genetics*; D006801:Humans; D000685:Serum Amyloid A Protein / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism
chemical_list: D000685:Serum Amyloid A Protein